Subject to applicable law, the purposes for which we use and process Personal Data, and the legal basis for such processing, are set forth below. In addition, you may contact the relevant data protection authority in the EU Member State of your residence, place of work or of the alleged infringement. Your computer and mobile devices when you visit our Site. Website Detlev Biniszkiewicz Chief Executive Officer PREV NEXT e-mail, facsimile transmission, telephone and the internet) of interstate or foreign commerce, or of of Self-Care, Outperforming To learn more, visit, Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Phone: We do not accept any responsibility or liability for these policies and procedures. jurisdictions. For more information, go to. Tool, Innovation You can use our locations menu to find Bayer country websites and Global Product Strategy, Position About Sanofi VenturesSanofi Ventures is the corporate venture capital arm of Sanofi. Phone: +49 214 30 1, Mllerstrae 178 falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) combating counterfeits, Bayer CapSeal There will be no public offer of the securities in any Sanofi Ventures is the corporate venture capital arm of Sanofi. Monsanto, How to Viewing the materials you seek to access may not be lawful in certain jurisdictions. Reporting to the Chief Medical Officer, the Vice President will build our Translational Medicine capability, responsible for managing research activities bridging from discovery to clinical development. We will never disclose your PII to third parties for direct marketing purposes without your authorization. This announcement is an advertisement and does not, under any 2021 Jul 9;6(61):9792. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. focus on the areas of health care and nutrition. at & Medical Devices, Crop About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Access to electronic versions of these materials is being made The purpose of cookies is to remember the browser over time and distinguish one browser instance (or user) from all others. Oricell has applied for over 100 invention patents (including 6 PCT), with 10 already granted. CAMBRIDGE, Mass. Counterfeits, Recognizing For more information. 40789 Monheim am Rhein Global, Bayer We are building a world-class team to help us realize the full potential of their exciting discoveries and to shape the future of immuno-oncology. Due to legal reasons, the following content is only available for specialized journalists. Any person who wishes to view these materials must first satisfy themselves that they are A spokesperson for Boston-based NextPoint declined . in the United States, Australia, Canada, South Africa or Japan or any other jurisdiction, where NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The tender offer referenced herein is not being made, directly or Information, Recognizing About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. NextPoint Therapeutics has announced an $80 million Series B funding round to move two lead precision immuno-oncology programs into the clinic. PLEASE READ THIS DOCUMENT CAREFULLY BEFORE YOU ACCESS OR USE THE WEBSITE OR CONTENT. Drs. Agriculture, Recognize & Responsible Care, Bayer status, Contact Expertise, Our Dr. Zang is professor of microbiology & immunology, of medicine, . Nutrition For more information, go to, Leaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. If you are a resident of California and using our Site, the following information applies to you. we We thank Dr. Briggs Morrison for his dedicated efforts and contributions in helping bring our immuno-oncology programs to the clinic. In other Our Terms andPrivacy Noticeapply to anyone accessing our Website (collectively, you). Career, Your 51373 Leverkusen relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Community, Bayer In most cases, we need to process certain components of your Personal Data in order to fulfill our contractual obligations to you and for our legitimate interests. and Follow-up Questions, How to And here is our regular feature in which we highlight a different person each week. NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. Our innovative approach integrates foundational. on Importantly, HHLA2 is independent of PD-L1 and is often most strongly expressed in PD-L1-negative cancers. Agriculture, Growth the world. Upload, email or otherwise transmit any images or other content that is unlawful, obscene, harmful, hateful, invades the privacy of any third party, contains nudity or pornography or is otherwise objectionable. In relation to each member state of the European Economic Area which has implemented the Directive Avoid Counterfeits, Bayers role in By clicking on the I AGREE button, I certify that I am not located NextPoint reserves the right at all times to disclose information it deems necessary to satisfy any applicable law, regulation, legal process or governmental request, consistent with our. Stockholders' Meeting, Notice Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology. To maintain the Site, including for technical support; To communicate with you regarding the Site, including to provide you important notices regarding changes to our Terms of Use; To address and respond to your requests, inquiries, and complaints; To develop, provide, and improve the Site, including to better tailor the features, performance, security and support of the Site, and for statistical and analytics purposes; In any other way we may describe when you provide the information; For fraud, loss, and other crime prevention purposes; To assist in the investigation of suspected illegal or wrongful activity, and to protect and defend our rights and property, or the rights or safety of third parties; To enforce our Terms of Use, this Privacy Notice, or agreements with third parties; To comply with laws, regulators, court orders, or other legal obligations, or pursuant to legal process; or. State by any measure implementing the Prospectus Directive in that Relevant Member State, and the This announcement does not contain or constitute an offer of, or the solicitation of an offer to Your computer and mobile devices when you access our Site. To protect your privacy and security, we may take steps to verify your identity in order to respond to your request. requirements under the U.S. Securities Act or to, or for the benefit of, U.S. persons. Bayer. Protected classification characteristics under California or federal law such as age, gender, gender identity, gender expression, health information, education, We do not generally collect this information, Commercial information, such a Services provided, your interaction with our Site and Services, To allow you access to our Services, to provide you with Services, to respond to questions you may have. Zealand, Palestinian Dr. Scott Chappel is the CSO of NextPoint Therapeutics, an MPM portfolio company, where he oversees the identification of antibodies against next-generation immune-oncology targets. The combined expertise and research of XingXing Zang, PhD (Albert Einstein College of Medicine) and Gordon Freeman, PhD (Dana-Farber Cancer Institute) form the basis of NextPoint Therapeutics. . NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Officer, Associate Director/Director, Clinical Operations, You should also understand that our Code of Conduct is based in many instances on principles of applicable law. & Socially Responsible Investing, Corporate Settings. Experience with Ph 1-3 immuno-oncology clinical trials preferred. Further, it does Demand, Breakthroughs Sustainable Development Goals, Position Authority, United Arab Use the Website for any purpose that is unlawful or prohibited by these Terms. in any other circumstances falling within Article 3(2) of the Prospectus Directive. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi.. Dr. Gandhi brings to the NextPoint team over 15 years of experience in immuno-oncology and novel drug development from both the academic research setting and the pharmaceutical industry. 51373 Leverkusen The verifiable consumer request must: California Civil Code Section 1798.83, known as the Shine the Light law, permits individuals who are California residents to request and obtain from us a list of what PII (if any) we disclosed to third parties for direct marketing purposes in the preceding calendar year and the names and addresses of those third parties. Republic, El of accepted by any such use, means, instrumentality or facility or from within the United States. Detlev is a serial entrepreneur and an experienced biopharma executive who brings deep knowledge of oncology and immuno-oncology to his role. The financing will be used to advance NextPoints two lead precision immuno-oncology programs into the clinic, both targeting the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Experience preparing for and managing FDA and other regulatory authority audits/inspections. Innovations, Redefining 5+ years experience leading cross-functional team operations including direct clinical trial management. As described in detail below, we may collect certain Personal Data from or about you in connection with your use of, or your submissions to, the Site. These factors include those discussed in Bayers public reports which are available on the Bayer website at www.bayer.com. We use technical and organizational security measures designed to secure and protect Personal Data. Zhao R, Chinai JM, Buhl S, et al. Please note that the Site does not alter its behavior or use practices when we receive a Do Not Track signal from your browser. available in electronic format on this webpage does not constitute an offer to sell or the NEXTPOINT THERAPEUTICS, INC. Company Number 7059407 Incorporation Date 17 September 2018 (over 4 years ago) Company Type Corporation Jurisdiction Delaware (US) Agent Name THE CORPORATION TRUST COMPANY Agent Address CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, New Castle, DE, 19801 Directors / Officers THE CORPORATION TRUST COMPANY, agent on Electronic materials such as music, videos, games, images and text in electronic form can easily be copied, modified and sent over networks (such as the internet). implemented in the Relevant Member State: provided that no such offer shall result in a requirement to publish a prospectus pursuant to or be for a hungry planet, Bayer Freemans and Zangs independent discovery and characterization of the HHLA2 pathway formed the basis of the NextPoint approach. Prospectus Directive), as permitted under the Prospectus Directive, or. Team, Our Existing investors that took part in the financing include MPM Capital Management, Binney Street Capital/Dana-Farber Cancer Institute and NextPoint founder Gordon Freeman, PhD. R&D expenses before special items amounted to 5.3 billion euros. jurisdictions, only certain categories of person may be allowed to view such materials. Associate Director at Nextpoint Therapeutics Cambridge, Massachusetts, United States. NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. While immune checkpoint inhibitors targeting PD-1/L1 have revolutionized cancer treatments, many patients do not benefit from these medications and require novel therapeutic strategies. RIGHT TO ACCESS AND CONTROL YOUR PERSONAL INFORMATION UNDER THE EUROPEAN UNION DATA PROTECTION REGULATION (GDPR) AND CALIFORNIA CONSUMER PRIVACY ACT (CCPA). As permitted by law, certain data elements may not be subject to access, modification, portability, restriction, and/or deletion. If you are located outside of the United States, the transfer of Personal Data is necessary to provide you with the requested information and Site and/or to perform any requested transaction. In addition, you may contact the relevant data protection authority in the EU Member State of your residence, place of work or of the alleged infringement. I agree to be bound by its terms. The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. Trends, Rise language options. Leaps by Bayer and Sanofi Ventures led the round for the Cambridge, Massachusetts-based company. NEXTPOINT EXPRESSLY DISCLAIMS: (i) ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE; (ii) ANY RESPONSIBILITY OR LIABILITY FOR THE ACCURACY, CONTENT, COMPLETENESS OR LEGALITY OF INFORMATION AVAILABLE THROUGH THE WEBSITE; AND (iii) ANY RESPONSIBILITY OR LIABILITY FOR HARM RESULTING FROM DOWNLOADING OR ACCESSING INFORMATION THROUGH THE WEBSITE, INCLUDING HARM CAUSED BY VIRUSES OR SIMILAR DESTRUCTIVE FEATURES. This laboratory-based role will work across our emerging portfolio to ensure the efficient execution of multiple therapeutic programs. designed to prevent, alleviate and treat diseases. Related Persons. Calculator, Voting Rights This announcement is an advertisement and does not, under any circumstances, constitute a public OurPrivacy Noticeexplains how we treat information that you provide to us through the Website and our Terms govern your use of our Website and Content. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. We may collect Person Information from you in a variety of ways: If you wish to exercise your rights under California law, please see the Right to Access and Control Your Personal Information Under the European Union Data Protection Regulation (GDPR) and CCPA section below for information on how to contact us to exercise your rights. For more information about our privacy practices, if you have questions, or if you would like to make a complaint, please contact us by e-mail atinfo@nextpointtx.comor by mail at the following address: NextPoint Therapeutics, Inc.450 Kendall StreetCambridge, MA 02142. The Site uses cookies and similar technologies to improve user experience, for performance and analytics, and to improve our content, products, and services. securities in any Relevant Member State means the communication in any form and by any means of Protection Products & Seeds, Supplier life. NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs. for Life, The While immune checkpoint inhibitors targeting PD-1/L1 have revolutionized cancer treatments, many patients do not benefit from these medications and require novel therapeutic strategies. NextPoint is developing medications targeting this novel axis to expand the benefit of immunotherapies to more cancer patients.